A comparison of current neuroblastoma chemotherapeutics

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.1, 2004-01, pp. : 71-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cellular Immunotherapy for Neuroblastoma: A Review of Current Vaccine and Adoptive T Cell Therapeutics

Current Pharmaceutical Design, Vol. 15, Iss. 4, 2009-02 ,pp. : 424-429

Bentham Science Publishers

Access to resources Recommend Favorite

Ellipticines as DNA-Targeted Chemotherapeutics

Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-01 ,pp. : 575-591

Bentham Science Publishers

Access to resources Recommend Favorite

Colchicine Semisynthetics: Chemotherapeutics for Cancer?

Current Medicinal Chemistry, Vol. 20, Iss. 7, 2013-03 ,pp. : 892-898

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Prion Chemotherapeutics

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 1, 2009-02 ,pp. : 81-91

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Intraperitoneal Cancer Chemotherapeutics

By Hasovits Csilla Clarke Stephen

Clinical Pharmacokinetics, Vol. 51, Iss. 4, 2012-04 ,pp. : 203-224

Adis International

Access to resources Recommend Favorite